Metraipolis › archive › dc_d21eae4ae2cc

Research hotspots and trends of GLP-1 receptor agonists in the treatment of Parkinson's disease: a bibliometric analysis — Europe PMC PMID:42591537

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42591537
DOI
10.3389/fnins.2026.1894856
License (as archived)
solo-consultazione
Archived
2026-10-09T22:51:05.165Z
SHA-256 of the archived text
743a34c5bd3095c1a383f8a7a47d4bbb91116f63de8382ccc9f6b8e389a1464d
Stable URL of this page
https://metraipolis.com/documento/dc_d21eae4ae2cc

How to cite

Research hotspots and trends of GLP-1 receptor agonists in the treatment of Parkinson's disease: a bibliometric analysis — Europe PMC PMID:42591537 — Europe PMC (en), https://europepmc.org/article/MED/42591537 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d21eae4ae2cc (Metraipolis archive dc_d21eae4ae2cc, sha256 743a34c5bd3095c1a383f8a7a47d4bbb91116f63de8382ccc9f6b8e389a1464d)
BibTeX
@misc{dcd21eae4ae2cc,
  title = {Research hotspots and trends of GLP-1 receptor agonists in the treatment of Parkinson's disease: a bibliometric analysis — Europe PMC PMID:42591537},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42591537},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d21eae4ae2cc; sha256 743a34c5bd3095c1a383f8a7a47d4bbb91116f63de8382ccc9f6b8e389a1464d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42591537. Agents can read the archived copy with the MCP tool read_document.